The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma—A report by the Polish Myeloma Study Group
Titel:
The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma—A report by the Polish Myeloma Study Group
Auteur:
Dmoszynska, Anna Walter-Croneck, Adam Hus, Iwona Grzasko, Norbert Manko, Joanna Jedrzejczak, Wieslaw Wiktor Charlinski, Grzegorz Usnarska-Zubkiewicz, Lidia Skotnicki, Aleksander Wolska-Smolen, Teresa Piszcz, Jaroslaw Kloczko, Janusz